These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24659892)

  • 1. Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression.
    Lee SH; Do SI; Kim HS
    World J Gastroenterol; 2014 Mar; 20(11):3011-7. PubMed ID: 24659892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10.
    Shi MN; Huang YH; Zheng WD; Zhang LJ; Chen ZX; Wang XZ
    World J Gastroenterol; 2006 Apr; 12(15):2357-62. PubMed ID: 16688825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease.
    Goto M; Hoxha N; Osman R; Wen J; Wells RG; Dell KM
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):639-44. PubMed ID: 20400910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apoptosis in neonatal rat lung exposed to hyperoxia].
    Li YX; Luo XP; Liao LJ; Liu WJ; Ning Q
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):585-90. PubMed ID: 16191268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats.
    Ling H; Roux E; Hempel D; Tao J; Smith M; Lonning S; Zuk A; Arbeeny C; Ledbetter S
    PLoS One; 2013; 8(1):e54499. PubMed ID: 23349909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
    Song SL; Gong ZJ; Zhang QR; Huang TX
    World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
    Ryu SH; Chung YH; Lee JK; Kim JA; Shin JW; Jang MK; Park NH; Lee HC; Lee YS; Suh DJ
    Liver Int; 2009 Feb; 29(2):308-14. PubMed ID: 18564211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia upregulates Cxcl12 in hepatocytes by a complex mechanism involving hypoxia-inducible factors and transforming growth factor-β.
    Strickland J; Garrison D; Copple BL
    Cytokine; 2020 Mar; 127():154986. PubMed ID: 31951966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats.
    Lang Q; Liu Q; Xu N; Qian KL; Qi JH; Sun YC; Xiao L; Shi XF
    Biochem Biophys Res Commun; 2011 Jun; 409(3):448-53. PubMed ID: 21600192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.
    Calabrese F; Valente M; Giacometti C; Pettenazzo E; Benvegnu L; Alberti A; Gatta A; Pontisso P
    J Gastroenterol Hepatol; 2003 Nov; 18(11):1302-8. PubMed ID: 14535988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus Calmette-Guerín vaccination: a novel therapeutic approach to preventing hyperoxic lung injury.
    Kumral A; İşcan B; Tuzun F; Micili SC; Arslan MK; Tugyan K; Duman N; Ozkan H
    J Matern Fetal Neonatal Med; 2015 Nov; 28(16):1950-6. PubMed ID: 25586318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury.
    Buckley S; Shi W; Barsky L; Warburton D
    Am J Physiol Lung Cell Mol Physiol; 2008 Apr; 294(4):L739-48. PubMed ID: 18245268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of TGF-beta 3 peptide activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia.
    Buckley S; Bui KC; Hussain M; Warburton D
    Am J Physiol; 1996 Jul; 271(1 Pt 1):L54-60. PubMed ID: 8760132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibrosis.
    Chang XM; Chang Y; Jia A
    World J Gastroenterol; 2005 May; 11(17):2634-6. PubMed ID: 15849824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of IL-10 on the expression of HSC growth factors in hepatic fibrosis rat.
    Shi MN; Zheng WD; Zhang LJ; Chen ZX; Wang XZ
    World J Gastroenterol; 2005 Aug; 11(31):4788-93. PubMed ID: 16097045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.